Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFRmutation

Overview of attention for article published in BMC Cancer, May 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 3 X users
patent: 1 patent

facebook: 1 Facebook page

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COBINATION WITH ANAPLASTIC…

Application WO-2020030977-A3

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.